Daiichi Sankyo Company, LTD Sample Contracts

CONTINGENT VALUE RIGHTS AGREEMENT
Contingent Value Rights Agreement • October 28th, 2014 • Daiichi Sankyo Company, LTD • Pharmaceutical preparations • Delaware

THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September [ ], 2014 (this “Agreement”), is entered into by and between Daiichi Sankyo Company, Limited, a Japanese corporation with its principal office at 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan (“Parent”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation, as Rights Agent (together with Parent, the “Parties”).

AutoNDA by SimpleDocs
Sales Agreement for EVISTA® Reached in Europe
Daiichi Sankyo Company, LTD • July 14th, 2006 • Pharmaceutical preparations

Tokyo, July 14, 2006 – DAIICHI SANKYO EUROPE GmbH (Headquarters: Munich, Germany), the European subsidiary of DAIICHI SANKYO’s wholly-owned subsidiary, Sankyo Co., Ltd. (President: Yasuhiro Ikegami; hereafter Sankyo), and Eli Lilly and Company have signed a marketing and distribution agreement for EVISTA® (raloxifene), an osteoporosis drug, in certain European countries (Germany, Italy, Belgium, Netherlands, Austria, and Switzerland).

CONFIDENTIALITY AGREEMENT
Confidentiality Agreement • October 10th, 2014 • Daiichi Sankyo Company, LTD • Pharmaceutical preparations • Delaware

THIS CONFIDENTIALITY AGREEMENT (“Agreement”) is being entered into as of July 31, 2014 (the “Effective Date”) between AMBIT BIOSCIENCES CORPORATION, a Delaware corporation (“Ambit”) and DAIICHI SANKYO, INC., a Delaware Corporation (“Daiichi Sankyo’’).

The Termination of the Contract concerning OTC Medicine
Daiichi Sankyo Company, LTD • September 21st, 2006 • Pharmaceutical preparations

Novartis Pharma K. K. (head office in Minato-ku, Tokyo: Nobuyuki Baba, President) and Sankyo Co., Ltd. (head office in Chuo-ku, Tokyo: Yasuhiro Ikegami, President) which is the affiliate of Daiichi Sankyo Co., Ltd. (head office in Chuo-ku, Tokyo: Takashi Shoda, President) have agreed to terminate the agreement concluded in January 2004 concerning Lamisil and Nicotinell TTS at the end of December, 2006.

Time is Money Join Law Insider Premium to draft better contracts faster.